Driven by Innovation

Disciplined by our Operating Model

Delivering Performance

Current stock performance

$107.72 - 0.14
26 May 2017

 

Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | Financial Tear Sheet Financial Tear Sheet
News Release
Printer Friendly Version View printer-friendly version
Download PDF version Download PDF version
<< Back
IDEX Corporation Reports Third Quarter 2011 Results; 28% Sales Growth, 26% Orders Growth and Record Free Cash Flow

LAKE FOREST, Ill., Oct 19, 2011 (BUSINESS WIRE) -- IDEX Corporation (NYSE: IEX) today announced its financial results for the three-month period ended September 30, 2011.

New orders in the quarter totaled $480 million, up 26 percent over the prior-year period. Sales in the quarter totaled $477 million, 28 percent higher than the prior-year period.

Third quarter adjusted operating income of $87 million (adjusted for a $12.8 million CVI Melles Griot non-cash acquisition fair value inventory charge and $2.9 million of restructuring related charges), was 18.3 percent of sales, up 70 basis points from the prior-year adjusted operating margin. On a reported basis, third quarter operating income of $71 million was 15.0 percent of sales, down 170 basis points from the prior year.

Excluding the effect of the inventory and restructuring charges referenced above, adjusted EPS was 71 cents, 42 percent higher than prior-year adjusted EPS of 50 cents. Third quarter EPS also benefitted 6 cents versus prior guidance due to a year-to-date true-up of the effective tax rate (ETR). Compared to the 32 percent ETR assumption in prior guidance, the company has lowered the projected ETR to 30 percent for the fourth quarter and 2012.

Highlights

  • Orders increased 26 percent compared to the prior year (+8 percent organic, +15 percent acquisition and +3 percent foreign currency translation).
  • Sales increased 28 percent compared to the prior year (+9 percent organic, +16 percent acquisition and +3 percent foreign currency translation).
  • Reported net income of $48 million was $10 million, or 25 percent, higher than the prior-year reported net income.
  • Reported EPS of 58 cents was 11 cents, or 23 percent, higher than the prior-year reported EPS.
  • Adjusted EPS of 71 cents was 21 cents, or 42 percent, higher than the prior-year adjusted EPS.
  • Adjusted EBITDA of $107 million was over 22 percent of sales and covered interest expense by nearly 14 times.
  • Free cash flow was $86 million, or nearly 180% of net income.

"I am extremely pleased with our third quarter results, especially our record free cash flow conversion. Our Fluid and Metering segment led the way with organic revenue growth of 16 percent with significant expansion in operating margins. As expected, acquisitions had a dilutive impact to our operating margins of approximately 80 basis points, primarily due to ongoing CVI intangible amortization expense. The impact was planned and we expect CVI's margin to expand through a combination of organic growth, operational synergies and structured cost take-out.

On an apples-to-apples basis, our third quarter year-over-year operating margins improved by 130 basis points, when normalized for the following: CVI inventory step-up charges, restructuring charges, acquisition impact and a third quarter 2011 benefit of $2.7 million from the reversal of previously recorded CEO compensation costs. This improvement was driven by excellent operational performance on strong organic revenue growth.

As we look into the fourth quarter and 2012, the indicators are mixed. Our infrastructure served markets continue to be robust globally, while selective end markets and geographies have moderated. As a result, we will execute a balanced approach of continuing to invest for growth in faster growing markets and our high-value platforms, while restructuring the business to take advantage of our available footprint.

Given this environment, we are projecting fourth quarter 2011 organic revenue growth of 4 to 5 percent and diluted EPS to range from 60 to 63 cents and full year adjusted diluted EPS to be $2.51 to $2.54, up 26 to 28 percent versus 2010. In the current economic environment, our preliminary view of 2012 indicates that we will achieve solid, profitable growth and outstanding cash generation."

Andrew K. Silvernail
Chief Executive Officer

Third Quarter 2011 Business Highlights (excluding non-cash acquisition fair-value inventory and restructuring related charges)

Fluid & Metering Technologies

  • Sales in the third quarter of $202 million reflected a 19 percent increase compared to the third quarter of 2010 (+16 percent organic and +3 percent foreign currency translation).
  • Operating margin of 19.9 percent represented a 160 basis point improvement compared with the third quarter of 2010 primarily related to improved productivity and cost reduction initiatives.

Health & Science Technologies

  • Sales in the third quarter of $177 million reflected a 59 percent increase compared to the third quarter of 2010 (+4 percent organic, +54 percent acquisitions and +1 percent foreign currency translation).
  • Operating margin of 19.2 percent represented a 380 basis point decrease compared with the third quarter of 2010 as a result of newly acquired businesses contributing margins below IDEX-like levels.

Dispensing Equipment

  • Sales in the third quarter of $25 million reflected a 5 percent decrease compared to the third quarter of 2010 (-11 percent organic and +6 percent foreign currency translation).
  • Operating margin of 9 percent was a 120 basis point decline compared to the third quarter of 2010 primarily due to lower volumes partially offset by improved productivity and cost reduction initiatives.

Fire & Safety/Diversified Products

  • Sales in the third quarter of $74 million reflected a 10 percent increase compared to the third quarter of 2010 (+6 percent organic and +4 percent foreign currency translation).
  • Operating margin of 25.4 percent was consistent with the third quarter of 2010.

For the third quarter of 2011, Fluid & Metering Technologies contributed 43 percent of sales and 42 percent of operating income; Health & Science Technologies accounted for 37 percent of sales and 36 percent of operating income; Dispensing Equipment accounted for 5 percent of sales and 2 percent of operating income; and Fire & Safety/Diversified Products represented 15 percent of sales and 20 percent of operating income.

A Note on EBITDA and Free Cash Flow

EBITDA means earnings before interest, income taxes, depreciation and amortization, while free cash flow means cash flow from operating activities less capital expenditures plus the excess tax benefit from stock-based compensation. Management uses these non-GAAP financial measures as internal operating metrics and for enterprise valuation purposes. Management believes these measures are useful as analytical indicators of leverage capacity and debt servicing ability, and uses them to measure financial performance as well as for planning purposes. However, they should not be considered as alternatives to net income, cash flow from operating activities or any other items calculated in accordance with U.S. GAAP, or as an indicator of operating performance. The definitions of EBITDA and free cash flow used here may differ from those used by other companies.

EBITDA and Free Cash Flow bridge For the Quarter Ended

September 30,

June 30,

2011

2010

Change

2011

Change

-- Income before Taxes

$63.1 $57.2 10 % $73.3 (14) %

-- Depreciation and Amortization

20.5 15.2 35 17.0 21

-- Interest

7.8 4.2 86 6.7 16

-- EBITDA

91.4 76.6 19 97.0 (6)

-- CVI Fair Value Inventory

12.8 - 100 3.0 n/m

-- Restructuring

2.9 3.5 (17) - 100

-- Adjusted EBITDA

$107.1 $80.1 34 $100.0 7

-- Cash Flow from Operating Activities

$94.8

$61.6

54

%

$51.7

83

%

-- Capital Expenditures

(9.4) (8.5) 11 (7.2) 31

-- Excess Tax Benefit from Stock-Based Compensation

0.9

1.0

(8)

1.6

(45)

-- Free Cash Flow

$86.3 $54.1 59 $46.1 87

Conference Call to be Broadcast over the Internet

IDEX will broadcast its third quarter earnings conference call over the Internet on Thursday, October 20, 2011 at 9:30 a.m. CT. Andrew Silvernail, Chief Executive Officer, Heath Mitts, Vice President and Chief Financial Officer and Larry Kingsley, Chairman will discuss the company's recent financial performance and respond to questions from the financial analyst community. IDEX invites interested investors to listen to the call and view the accompanying slide presentation, which will be carried live on its website at http://www.idexcorp.com. Those who wish to participate should log on several minutes before the discussion begins. After clicking on the presentation icon, investors should follow the instructions to ensure their systems are set up to hear the event and view the presentation slides, or download the correct applications at no charge. Investors will also be able to hear a replay of the call by dialing 855.859.2056 (or 404.537.3406 for international participants) using the ID # 66069195.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act of 1934, as amended. These statements may relate to, among other things, capital expenditures, cost reductions, cash flow, and operating improvements and are indicated by words or phrases such as "anticipate," "estimate," "plans," "expects," "projects," "should," "will," "management believes," "the company believes," "the company intends," and similar words or phrases. These statements are subject to inherent uncertainties and risks that could cause actual results to differ materially from those anticipated at the date of this news release. The risks and uncertainties include, but are not limited to, the following: economic and political consequences resulting from terrorist attacks and wars; levels of industrial activity and economic conditions in the U.S. and other countries around the world; pricing pressures and other competitive factors, and levels of capital spending in certain industries - all of which could have a material impact on order rates and IDEX's results, particularly in light of the low levels of order backlogs it typically maintains; its ability to make acquisitions and to integrate and operate acquired businesses on a profitable basis; the relationship of the U.S. dollar to other currencies and its impact on pricing and cost competitiveness; political and economic conditions in foreign countries in which the company operates; interest rates; capacity utilization and the effect this has on costs; labor markets; market conditions and material costs; and developments with respect to contingencies, such as litigation and environmental matters. The forward-looking statements included here are only made as of the date of this news release, and management undertakes no obligation to publicly update them to reflect subsequent events or circumstances. Investors are cautioned not to rely unduly on forward-looking statements when evaluating the information presented here.

About IDEX

IDEX Corporation is an applied solutions company specializing in fluid and metering technologies, health and science technologies, dispensing equipment, and fire, safety and other diversified products built to its customers' exacting specifications. Its products are sold in niche markets to a wide range of industries throughout the world. IDEX shares are traded on the New York Stock Exchange and Chicago Stock Exchange under the symbol "IEX."

For further information on IDEX Corporation and its business units, visit the company's Web site at www.idexcorp.com.

(Tables follow)

IDEX CORPORATION
Condensed Statements of Consolidated Operations
(in thousands except per share amounts)
(unaudited)
Three Months Ended Nine Months Ended
September 30, September 30,
2011 2010 2011 2010
Net sales $ 476,881 $ 373,731 $ 1,357,768 $ 1,107,855
Cost of sales 295,349 219,598 812,697 651,360
Gross profit 181,532 154,133 545,071 456,495
Selling, general and administrative expenses 107,296 88,170 313,485 266,961
Restructuring expenses 2,931 3,524 2,931 6,422
Operating income 71,305 62,439 228,655 183,112
Other income (expense) - net (441 ) (1,101 ) (1,001 ) (608 )
Interest expense 7,763 4,162 20,937 11,195
Income before income taxes 63,101 57,176 206,717 171,309
Provision for income taxes 14,765 18,612 60,248 55,722
Net income $ 48,336 $ 38,564 $ 146,469 $ 115,587
Earnings per Common Share:
Basic earnings per common share (a) $ 0.58 $ 0.47 $ 1.77 $ 1.42
Diluted earnings per common share (a) $ 0.58 $ 0.47 $ 1.75 $ 1.40
Share Data:
Basic weighted average common shares outstanding 82,402 80,517 81,994 80,322
Diluted weighted average common shares outstanding 83,586 81,938 83,533 81,749
Condensed Consolidated Balance Sheets
(in thousands)
(unaudited)
September 30, December 31,
2011 2010
Assets
Current assets
Cash and cash equivalents $ 220,461 $ 235,136
Receivables - net 258,346 213,553
Inventories 271,617 196,546
Other current assets 54,882 47,523
Total current assets 805,306 692,758
Property, plant and equipment - net 219,702 188,562
Goodwill and intangible assets 1,835,587 1,488,393
Other noncurrent assets 33,133 11,982
Total assets $ 2,893,728 $ 2,381,695
Liabilities and shareholders' equity
Current liabilities
Trade accounts payable $ 119,738 $ 104,055
Accrued expenses 173,854 117,879
Short-term borrowings 85,395 119,445
Dividends payable 14,172 12,289
Total current liabilities 393,159 353,668
Long-term borrowings 733,204 408,450
Other noncurrent liabilities 261,944 243,917
Total liabilities 1,388,307 1,006,035
Shareholders' equity 1,505,421 1,375,660
Total liabilities and shareholders' equity $ 2,893,728 $ 2,381,695
IDEX CORPORATION
Company and Business Group Financial Information
(dollars in thousands)
(unaudited)
Three Months Ended Nine Months Ended
September 30, (b) September 30, (b)
2011 2010 (c) 2011 2010 (c)
Fluid & Metering Technologies
Net sales $ 201,944 $ 169,770 $ 602,468 $ 505,681
Operating income (d) 40,097 31,122 120,622 92,485
Operating margin 19.9 % 18.3 % 20.0 % 18.3 %
Depreciation and amortization $ 8,577 $ 8,046 $ 24,757 $ 23,678
Capital expenditures 3,301 3,356 9,808 12,987
Health & Science Technologies
Net sales $ 176,764 $ 111,430 $ 454,518 $ 310,952
Operating income (d) (e) 33,880 25,645 96,059 67,457
Operating margin 19.2 % 23.0 % 21.1 % 21.7 %
Depreciation and amortization $ 9,738 $ 4,929 $ 20,770 $ 13,401
Capital expenditures 4,607 2,298 9,930 6,102
Dispensing Equipment
Net sales $ 25,143 $ 26,480 $ 93,447 $ 101,169
Operating income (d) 2,258 2,711 18,274 19,182
Operating margin 9.0 % 10.2 % 19.6 % 19.0 %
Depreciation and amortization $ 595 $ 816 $ 2,519 $ 2,980
Capital expenditures 123 245 973 887
Fire & Safety/Diversified Products
Net sales $ 73,592 $ 66,993 $ 209,367 $ 194,385
Operating income (d) 18,707 17,045 50,698 44,509
Operating margin 25.4 % 25.4 % 24.2 % 22.9 %
Depreciation and amortization $ 1,249 $ 1,195 $ 4,042 $ 3,993
Capital expenditures 1,401 786 3,612 2,662
Company
Net sales $ 476,881 $ 373,731 $ 1,357,768 $ 1,107,855
Operating income (d)(e) 87,036 65,963 247,386 189,534
Operating margin 18.3 % 17.6 % 18.2 % 17.1 %
Depreciation and amortization (f) $ 20,540 $ 15,235 $ 53,116 $ 44,888
Capital expenditures 10,048 7,936 27,136 25,972
(a) Calculated by applying the two-class method of allocating earnings to common stock and participating securities as required by ASC 260, Earnings Per Share.
(b) Three and nine month data includes acquisitions of OBL (July 2010) in the Fluid & Metering Technologies Segment and CVI (June 2011), Microfluidics (March 2011), Advanced Thin Films (January 2011), Fitzpatrick (November 2010) and Seals-PPE (April 2010) in the Health & Science Technologies Segment from the date of acquisition.
(c) Financial data has been revised to reflect the movement of the Pharma group from the Fluid & Metering Technologies Segment to the Health & Science Technologies Segment.
(d) Group operating income excludes unallocated corporate operating expenses while both Group and Company operating income excludes restructuring related charges.
(e) Operating income excludes $12.8 million and $15.8 million for the three and nine months ending September 30, 2011, respectively, related to the CVI Melles Griot non-cash acquisition fair value inventory charge.
(f) Excludes amortization of debt issuance expenses.

SOURCE: IDEX Corporation

IDEX Corporation
Investor Contact:
Heath Mitts, (847) 498-7070
Vice President - Chief Financial Officer